Zurück zum Zitat Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. Jama. 2001;285(18):2370–5CrossRefPubMed Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. Jama. 2001;285(18):2370–5CrossRefPubMed

Zurück zum Zitat Camm AJ, Kirchhof P et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369–429CrossRefPubMed Camm AJ, Kirchhof P et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369–429CrossRefPubMed

Zurück zum Zitat Kirchhof P, Goette A, Gulba D et al. Kommentar zu den Leitlinien der ESC zum Vorhofflimmern. Kardiologe. 2012;6:12–27CrossRef Kirchhof P, Goette A, Gulba D et al. Kommentar zu den Leitlinien der ESC zum Vorhofflimmern. Kardiologe. 2012;6:12–27CrossRef

Zurück zum Zitat Van Gelder IC, Groenveld HF, Crijns HJ et al. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med. 2010;362(15):1363–73CrossRefPubMed Van Gelder IC, Groenveld HF, Crijns HJ et al. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med. 2010;362(15):1363–73CrossRefPubMed

Zurück zum Zitat Camm AJ, Lip GY, De Caterina R et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation—developed with the special contribution of the European Heart Rhythm Association. Europace. 2012;14(10):1385–413CrossRefPubMed Camm AJ, Lip GY, De Caterina R et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation—developed with the special contribution of the European Heart Rhythm Association. Europace. 2012;14(10):1385–413CrossRefPubMed

Zurück zum Zitat Bunch TJ, Crandall BG, Weiss JP et al. Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. J Cardiovasc Electrophysiol. 2011;22(8):839–45CrossRefPubMed Bunch TJ, Crandall BG, Weiss JP et al. Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. J Cardiovasc Electrophysiol. 2011;22(8):839–45CrossRefPubMed

Zurück zum Zitat Verma A, Jiang CY, Betts TR et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015;372(19):1812–22CrossRefPubMed Verma A, Jiang CY, Betts TR et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015;372(19):1812–22CrossRefPubMed

Zurück zum Zitat Gillinov AM, Gelijns AC, Parides MK et al. Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med. 2015;372(15):1399–409CrossRefPubMed Gillinov AM, Gelijns AC, Parides MK et al. Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med. 2015;372(15):1399–409CrossRefPubMed

Zurück zum Zitat Neven K, Schmidt B, Metzner A et al. Fatal end of a safety algorithm for pulmonary vein isolation with use of high-intensity focused ultrasound. Circ Arrhythm Electrophysiol. 2010;3(3):260–5CrossRefPubMed Neven K, Schmidt B, Metzner A et al. Fatal end of a safety algorithm for pulmonary vein isolation with use of high-intensity focused ultrasound. Circ Arrhythm Electrophysiol. 2010;3(3):260–5CrossRefPubMed

Zurück zum Zitat Calkins H, Kuck KH, Cappato R et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm. 2012;9(4):632–96 e21CrossRefPubMed Calkins H, Kuck KH, Cappato R et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm. 2012;9(4):632–96 e21CrossRefPubMed

Zurück zum Zitat Haissaguerre M, Jais P, Shah DC et al. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation. 2000;101(12):1409–17CrossRefPubMed Haissaguerre M, Jais P, Shah DC et al. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation. 2000;101(12):1409–17CrossRefPubMed

Zurück zum Zitat Herrera Siklody C, Deneke T, Hocini M et al. Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation: comparison of different atrial fibrillation ablation technologies in a multicenter study. J Am Coll Cardiol. 2011;58(7):681–8CrossRefPubMed Herrera Siklody C, Deneke T, Hocini M et al. Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation: comparison of different atrial fibrillation ablation technologies in a multicenter study. J Am Coll Cardiol. 2011;58(7):681–8CrossRefPubMed

Zurück zum Zitat De Greef Y, Boersma L, Dekker L et al. Phased RF evaluation of acute pulmonary vein isolation in paroxysmal AF with new genius and PVAC GOLD: the PRECISION-GOLD Study. Circulation. 2014;130(Suppl 2 A18975) De Greef Y, Boersma L, Dekker L et al. Phased RF evaluation of acute pulmonary vein isolation in paroxysmal AF with new genius and PVAC GOLD: the PRECISION-GOLD Study. Circulation. 2014;130(Suppl 2 A18975)

Zurück zum Zitat Fürnkranz A, Bordignon S, Dugo D et al. Improved 1-year clinical success rate of pulmonary vein isolation with the second-generation cryoballoon in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2014;25(8):840–4CrossRefPubMed Fürnkranz A, Bordignon S, Dugo D et al. Improved 1-year clinical success rate of pulmonary vein isolation with the second-generation cryoballoon in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2014;25(8):840–4CrossRefPubMed

Zurück zum Zitat Reddy VY, Dukkipati SR, Cuoco F et al. Visually-Guided Laser Balloon (VGLB) Pulmonary Vein Isolation for the Treatment of Paroxysmal Atrial Fibrillation (PAF): Results of the Prospective Multicenter Randomized HeartLight Study. Heart rhythm. 2015;May Supplemet (LBCT02-06) Reddy VY, Dukkipati SR, Cuoco F et al. Visually-Guided Laser Balloon (VGLB) Pulmonary Vein Isolation for the Treatment of Paroxysmal Atrial Fibrillation (PAF): Results of the Prospective Multicenter Randomized HeartLight Study. Heart rhythm. 2015;May Supplemet (LBCT02-06)

Zurück zum Zitat Bonanno C, Paccanaro M, La Vecchia L et al. Efficacy and safety of catheter ablation versus antiarrhythmic drugs for atrial fibrillation: a meta-analysis of randomized trials. J Cardiovasc Med. 2010;11(6):408–18CrossRef Bonanno C, Paccanaro M, La Vecchia L et al. Efficacy and safety of catheter ablation versus antiarrhythmic drugs for atrial fibrillation: a meta-analysis of randomized trials. J Cardiovasc Med. 2010;11(6):408–18CrossRef

Zurück zum Zitat Brooks AG, Stiles MK, Laborderie J et al. Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review. Heart rhythm. 2010;7(6):835–46CrossRefPubMed Brooks AG, Stiles MK, Laborderie J et al. Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review. Heart rhythm. 2010;7(6):835–46CrossRefPubMed

Zurück zum Zitat Chugh A, Oral H, Lemola K et al. Prevalence, mechanisms, and clinical significance of macroreentrant atrial tachycardia during and following left atrial ablation for atrial fibrillation. Heart rhythm. 2005;2(5):464–71CrossRefPubMed Chugh A, Oral H, Lemola K et al. Prevalence, mechanisms, and clinical significance of macroreentrant atrial tachycardia during and following left atrial ablation for atrial fibrillation. Heart rhythm. 2005;2(5):464–71CrossRefPubMed

Zurück zum Zitat Hussein AA, Saliba WI, Martin DO et al. Natural history and long-term outcomes of ablated atrial fibrillation. Circ Arrhythm Electrophysiol. 2011;4(3):271–8CrossRefPubMed Hussein AA, Saliba WI, Martin DO et al. Natural history and long-term outcomes of ablated atrial fibrillation. Circ Arrhythm Electrophysiol. 2011;4(3):271–8CrossRefPubMed

Zurück zum Zitat Kowey PR, Reiffel JA, Camm AJ et al. The effect of the combination of ranolazine and low dose dronedarone on atrial fibrillation burden in patients with paroxysmal atrial fibrillation (HARMONY Trial). Heart rhythm. 2014;May Supplement (Abstract LB03-05) Kowey PR, Reiffel JA, Camm AJ et al. The effect of the combination of ranolazine and low dose dronedarone on atrial fibrillation burden in patients with paroxysmal atrial fibrillation (HARMONY Trial). Heart rhythm. 2014;May Supplement (Abstract LB03-05)